![Michael Rosol](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Rosol
Geen lopende functies
Profiel
Michael S.
Rosol's former jobs include Chief Executive Officer at Atherion Bioresearch, Inc., Senior Director-Business Development at Elucid Bioimaging, Inc. in 2016, Associate Director-Clinical & Translational at Novartis Institutes for Biomedical Research, Inc. from 2016 to 2018, Chief Medical Officer & Senior Vice President at Navidea Biopharmaceuticals, Inc. from 2018 to 2023, Head-Translational Imaging Group at Novartis Pharmaceuticals Corp.
from 2012 to 2015, Chief Scientific Officer at Medilumine, Inc. from 2015 to 2016, and Chief Development Officer at Plus Therapeutics, Inc. from 2025 to 2026.
Education includes a doctorate from Boston University School of Medicine.
Eerdere bekende functies van Michael Rosol
| Bedrijven | Functie | Einde |
|---|---|---|
| CERENOME, INC. | Corporate Officer/Principal | 20-04-2026 |
| NAVIDEA BIOPHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 30-03-2023 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 01-12-2018 |
Elucid Bioimaging, Inc.
 Elucid Bioimaging, Inc. Packaged SoftwareTechnology Services Operates as an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient | Corporate Officer/Principal | 01-11-2016 |
Medilumine, Inc. | Corporate Officer/Principal | 01-05-2016 |
Opleiding van Michael Rosol
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
50
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Navidea Biopharmaceuticals, Inc.
 Navidea Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes precision diagnostics and radiopharmaceutical agents | Health Technology |
Elucid Bioimaging, Inc.
Elucid Bioimaging, Inc. Packaged SoftwareTechnology Services Operates as an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient | Technology Services |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Boston University School of Medicine
 Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medilumine, Inc. |
